220 related articles for article (PubMed ID: 20954067)
21. Characterization of hypoactive sexual desire disorder (HSDD) in men.
DeRogatis L; Rosen RC; Goldstein I; Werneburg B; Kempthorne-Rawson J; Sand M
J Sex Med; 2012 Mar; 9(3):812-20. PubMed ID: 22239825
[TBL] [Abstract][Full Text] [Related]
22. The Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS): psychometric properties within a Dutch population.
ter Kuile MM; Brauer M; Laan E
J Sex Marital Ther; 2006; 32(4):289-304. PubMed ID: 16709550
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a new screening tool for hypoactive sexual desire disorder: The Brief Profile of Female Sexual Function (B-PFSF).
Rust J; Derogatis L; Rodenberg C; Koochaki P; Schmitt S; Golombok S
Gynecol Endocrinol; 2007 Nov; 23(11):638-44. PubMed ID: 17926163
[TBL] [Abstract][Full Text] [Related]
24. The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder.
Sills T; Wunderlich G; Pyke R; Segraves RT; Leiblum S; Clayton A; Cotton D; Evans K
J Sex Med; 2005 Nov; 2(6):801-18. PubMed ID: 16422805
[TBL] [Abstract][Full Text] [Related]
25. Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
Kingsberg SA; Althof SE
J Sex Med; 2011 Dec; 8(12):3262-70. PubMed ID: 21883949
[TBL] [Abstract][Full Text] [Related]
26. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS).
Leiblum SR; Koochaki PE; Rodenberg CA; Barton IP; Rosen RC
Menopause; 2006; 13(1):46-56. PubMed ID: 16607098
[TBL] [Abstract][Full Text] [Related]
27. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores.
Wiegel M; Meston C; Rosen R
J Sex Marital Ther; 2005; 31(1):1-20. PubMed ID: 15841702
[TBL] [Abstract][Full Text] [Related]
28. From whence comes HSDD?
Parish SJ
J Fam Pract; 2009 Jul; 58(7 Suppl Hypoactive):S16-21. PubMed ID: 19825314
[TBL] [Abstract][Full Text] [Related]
29. Psychometric properties of the Female Sexual Distress Scale-Revised among a sample of non-clinical Iranian women.
Ghassami M; Asghari A; Shaeeri MR; Soltaninejad Z; Safarinejad MR
Int J Psychiatry Clin Pract; 2014 Oct; 18(4):293-9. PubMed ID: 24994478
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women.
West SL; D'Aloisio AA; Agans RP; Kalsbeek WD; Borisov NN; Thorp JM
Arch Intern Med; 2008 Jul; 168(13):1441-9. PubMed ID: 18625925
[TBL] [Abstract][Full Text] [Related]
31. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
Simon JA; Thorp J; Millheiser L
J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
[No Abstract] [Full Text] [Related]
32. The Sexual Event Diary (SED): Development and Validation of a Standardized Questionnaire for Assessing Female Sexual Functioning During Discrete Sexual Events.
van Nes Y; Bloemers J; van der Heijden PGM; van Rooij K; Gerritsen J; Kessels R; DeRogatis L; Tuiten A
J Sex Med; 2017 Nov; 14(11):1438-1450. PubMed ID: 28993148
[TBL] [Abstract][Full Text] [Related]
33. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
[TBL] [Abstract][Full Text] [Related]
34. Development and Validation of Turkish Version of The Female Sexual Distress Scale-Revised.
Aydın S; Onaran ÖI; Topalan K; Aydın ÇA; Dansuk R
Sex Med; 2016 Mar; 4(1):e43-50. PubMed ID: 26796854
[TBL] [Abstract][Full Text] [Related]
35. [Hypoactive sexual desire disorder, HSDD].
Mimoun S
Gynecol Obstet Fertil; 2011 Jan; 39(1):28-31. PubMed ID: 21186133
[TBL] [Abstract][Full Text] [Related]
36. Managing female sexual dysfunction.
Buster JE
Fertil Steril; 2013 Oct; 100(4):905-15. PubMed ID: 24074537
[TBL] [Abstract][Full Text] [Related]
37. Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.
Althof S; Derogatis LR; Greenberg S; Clayton AH; Jordan R; Lucas J; Spana C
J Sex Med; 2019 Aug; 16(8):1226-1235. PubMed ID: 31277966
[TBL] [Abstract][Full Text] [Related]
38. Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD).
Clayton AH; Goldfischer ER; Goldstein I; Derogatis L; Lewis-D'Agostino DJ; Pyke R
J Sex Med; 2009 Mar; 6(3):730-8. PubMed ID: 19170868
[TBL] [Abstract][Full Text] [Related]
39. Development and evaluation of the Women's Sexual Interest Diagnostic Interview (WSID): a structured interview to diagnose hypoactive sexual desire disorder (HSDD) in standardized patients.
DeRogatis LR; Allgood A; Rosen RC; Leiblum S; Zipfel L; Guo CY
J Sex Med; 2008 Dec; 5(12):2827-41. PubMed ID: 18823321
[TBL] [Abstract][Full Text] [Related]
40. Development of a Korean version of the Female Sexual Distress Scale.
Bae JH; Han CS; Kang SH; Shim KS; Kim JJ; Moon DG
J Sex Med; 2006 Nov; 3(6):1013-1017. PubMed ID: 17100934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
